 |
|
|
| |
An Open-Label, Multicenter Study of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin
in US Veterans With Genotype 1 Chronic Hepatitis C Infection: Efficacy and Safety Results of TOPAZ-VA.... .49% had ongoing psych disorders
|
| |
| |
Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
Michael Fuchs1, Timothy Morgan2, Mariem Charafeddine3, Norbert Bräu4, Warren Schmidt5, Michael Kozal6, Susanna Naggie7, Ramsey Cheung8, Tami Pilot-Mati as3, Yao Yu3, Kristi ne Richards3,
Victoria Mullally3, Daniel Cohen3, Alexander Monto9, Doris Toro10
1Hunter Holmes McGuire VA Medical Center, Richmond, Virginia, United States; 2VA Long Beach Healthcare System, Long Beach, California, United States; 3AbbVie Inc., North Chicago, Illinois, United States; 4James J. Peters VA Medical Center, Bronx, New York, United States; 5Iowa City VA Healthcare System, Iowa City, Iowa, United States; 6VA Connecticut Healthcare System and Yale University School of Medicine, New Haven, Connecticut, United States; 7Durham VA Medical Center, Durham, North Carolina, United States;
8VA Palo Alto Healthcare System, Palo Alto, California, United States; 9San Francisco VA Medical Center, San Francisco, California, United States; 10VA Caribbean Healthcare System, San Juan, Puerto Rico
|
| |
|
|
|
|
|
